AP9901515A0 - Reagent system and kit or detecting HIV infected cells. - Google Patents
Reagent system and kit or detecting HIV infected cells.Info
- Publication number
- AP9901515A0 AP9901515A0 APAP/P/1999/001515A AP9901515A AP9901515A0 AP 9901515 A0 AP9901515 A0 AP 9901515A0 AP 9901515 A AP9901515 A AP 9901515A AP 9901515 A0 AP9901515 A0 AP 9901515A0
- Authority
- AP
- ARIPO
- Prior art keywords
- cells
- present
- infected cells
- relates
- kit
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
This invention related to blood collection and diagnostics. More particularly, the invention relates to blood collection and diagnostics utilizing techniques such as magnetic separation and photodetection. The present invention also relates to methods and an apparatus for detecting the presence of antigens displayed on the surface of cells. More preferably, the present invention relates to the detection of cells infected by human immunodeficiency virus (hiv)and related viruses. In accordance with the present invention, hiv-infected cells can be detected and separated from uninfected cells. In a preferred embodiment, separation is achieved by a magnetic field. By coating the infected cells with magnetic particles, transfer of the cells to a precise location is facilitated. A novel aspect os the present invention is a cartridge antigen test which allows for the collection and mixing of blood with reagents in one package, which can be viewed on a fluoresent microscope.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/732,782 US5817458A (en) | 1996-10-15 | 1996-10-15 | Reagent system for detecting HIV-infected peripheral blood lymphocytes in whole blood |
US08/732,784 US5714390A (en) | 1996-10-15 | 1996-10-15 | Cartridge test system for the collection and testing of blood in a single step |
PCT/US1997/018649 WO1998016101A1 (en) | 1996-10-15 | 1997-10-15 | Reagent system and kit for detecting hiv infected cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AP9901515A0 true AP9901515A0 (en) | 1999-06-30 |
Family
ID=27112456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1999/001515A AP9901515A0 (en) | 1996-10-15 | 1997-10-15 | Reagent system and kit or detecting HIV infected cells. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0933989A1 (en) |
JP (1) | JP2001503859A (en) |
AP (1) | AP9901515A0 (en) |
AU (1) | AU743937B2 (en) |
WO (1) | WO1998016101A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010039007A1 (en) * | 1996-10-15 | 2001-11-08 | Robert Hallowitz | Methods and compositions for determining latent viral load |
AU2001271643A1 (en) * | 2000-06-30 | 2002-01-14 | Bio-Tech Imaging, Inc. | Methods for characterizing the viral infectivity status of host |
FR2832507B1 (en) | 2001-11-20 | 2004-02-20 | Stago Diagnostica | METHOD OF DETECTING ANALYTE (S) USING COLLOIDAL MAGNETIC PARTICLES |
WO2004031209A2 (en) * | 2002-10-01 | 2004-04-15 | Functional Genetics, Inc. | Anti-tsg101 antibodies and their uses for treatment of viral infections |
WO2006009398A1 (en) * | 2004-07-20 | 2006-01-26 | Cgk Co., Ltd. | System for detecting molecular interactions |
CN107290534A (en) * | 2017-07-12 | 2017-10-24 | 华讯方舟科技有限公司 | A kind of blood cell capture chip and method |
CN114908190A (en) * | 2022-04-29 | 2022-08-16 | 深圳市血液中心(深圳市输血医学研究所) | HIV DNA detection method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4659678A (en) * | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
FI844027A (en) * | 1984-10-12 | 1986-04-13 | Labsystems Oy | IMMUNOLOGISKT BESTAEMNINGSFOERFARANDE. |
EP0452342B1 (en) * | 1988-12-28 | 1994-11-30 | MILTENYI, Stefan | Methods and materials for high gradient magnetic separation of biological materials |
US5054499A (en) * | 1989-03-27 | 1991-10-08 | Swierczek Remi D | Disposable skin perforator and blood testing device |
US5541072A (en) * | 1994-04-18 | 1996-07-30 | Immunivest Corporation | Method for magnetic separation featuring magnetic particles in a multi-phase system |
US5231993A (en) * | 1991-11-20 | 1993-08-03 | Habley Medical Technology Corporation | Blood sampler and component tester with guide member |
-
1997
- 1997-10-15 EP EP97910976A patent/EP0933989A1/en not_active Withdrawn
- 1997-10-15 WO PCT/US1997/018649 patent/WO1998016101A1/en not_active Application Discontinuation
- 1997-10-15 AU AU48224/97A patent/AU743937B2/en not_active Ceased
- 1997-10-15 JP JP51858298A patent/JP2001503859A/en active Pending
- 1997-10-15 AP APAP/P/1999/001515A patent/AP9901515A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0933989A1 (en) | 1999-08-11 |
JP2001503859A (en) | 2001-03-21 |
AU4822497A (en) | 1998-05-11 |
WO1998016101A1 (en) | 1998-04-23 |
AU743937B2 (en) | 2002-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Constantine et al. | HIV testing technologies after two decades of evolution | |
CA2272881C (en) | Assay method for peptide specific t-cells | |
McHugh et al. | Simultaneous detection of antibodies to cytomegalovirus and herpes simplex virus by using flow cytometry and a microsphere-based fluorescence immunoassay | |
US7129056B2 (en) | Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood | |
AU655592B2 (en) | Hepatitis C assay utilizing recombinant antigens | |
JPH11237381A (en) | Method for fitting human or animal transplantation tissue to recipient and method for detecting tumor antigen in human or animal | |
AP9901515A0 (en) | Reagent system and kit or detecting HIV infected cells. | |
Damhorst et al. | Micro-and nanotechnology for HIV/AIDS diagnostics in resource-limited settings | |
Böni et al. | Sensitive detection and quantification of particle‐associated reverse transcriptase in plasma of HIV‐1‐infected individuals by the product‐enhanced reverse transcriptase (PERT) assay | |
EP0902286A2 (en) | Immunoassay utilizing two incubations with labelled antigen | |
CA2303123A1 (en) | Method for detecting antibodies in a sample | |
WO1995023973A3 (en) | Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents | |
ES2094124T3 (en) | IMMUNOLOGICAL TEST OF ANTIBODIES AGAINST HIV. | |
Nabatiyan et al. | A lateral flow-based ultra-sensitive p24 HIV assay utilizing fluorescent microparticles | |
Mas et al. | Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections | |
RU97115554A (en) | DETECTION OF ANTIBODY PRODUCTION | |
Vallari et al. | Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 | |
Miller | Profile of the MP Diagnostics HTLV Blot 2.4 test: a supplemental assay for the confirmation and differentiation of antibodies to HTLV-1 and HTLV-2 | |
Asihene et al. | Evaluation of rapid test for detection of antibody to human immunodeficiency virus type 1 and type 2 | |
Sommerfelt et al. | A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particles | |
CA2116026A1 (en) | Hepatitis c assay utilizing recombinant antigens to c-100 region | |
RU2002100350A (en) | Antibody analysis | |
Sirivichayakul et al. | Evaluation of a 2-minute anti-human immunodeficiency virus (HIV) test using the autologous erythrocyte agglutination technique with populations differing in HIV prevalence | |
RU2234700C2 (en) | Method for diagnosis of viral hepatitis b | |
Delaporte et al. | Interpretation of antibodies reacting solely with human retroviral core proteins in western equatorial Africa |